Literature DB >> 20946236

Successful treatment of disseminated mixed invasive fungal infection after hematopoietic stem cell transplantation for severe aplastic anemia.

Te-Fu Weng1, Mao-Wang Ho, Hsiao-Chuan Lin, Meng-Yao Lu, Ching-Tien Peng, Kang-Hsi Wu.   

Abstract

Concomitant infections are frequent and usually the causes of death in patients with severe AA. HSCT can restore hematopoiesis in AA, but it is usually life threatening when patients simultaneously have an IFI. Mixed IFIs have been reported on rare occasions. The exact diagnosis of IFIs is difficult because of low fungus culture rate, difficultly obtaining tissue specimens in severely immunocompromised patients or those with bleeding tendencies. Otherwise, treatment with anti-fungal drugs alone for DMIFI was always lethal in previous reports. Surgical resection is crucial for invasive zygomycosis, but severe pancytopenia and bleeding tendency make therapy difficult. Herein, we report that with a combination of aggressive anti-fungal drugs, HSCT, and surgery, we successfully treated a 10-yr-old boy with severe AA and pulmonary zygomycosis before HSCT and disseminated mixed invasive zygomycosis and aspergillosis after HSCT.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946236     DOI: 10.1111/j.1399-3046.2010.01406.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

Review 1.  Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.

Authors:  Maddalena Chermetz; Margherita Gobbo; Katia Rupel; Giulia Ottaviani; Giancarlo Tirelli; Rossana Bussani; Roberto Luzzati; Roberto Di Lenarda; Matteo Biasotto
Journal:  Mycopathologia       Date:  2016-06-27       Impact factor: 2.574

Review 2.  Pulmonary Mucormycosis Over 130 Years: A Case Report and Literature Review.

Authors:  Hasan S Yamin; Amro Y Alastal; Izzedin Bakri
Journal:  Turk Thorac J       Date:  2017-01-01

Review 3.  Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.

Authors:  Yasasve Madhavan; Kadambari Vijay Sai; Dilip Kumar Shanmugam; Aashabharathi Manimaran; Karthigadevi Guruviah; Yugal Kishore Mohanta; Divyambika Catakapatri Venugopal; Tapan Kumar Mohanta; Nanaocha Sharma; Saravanan Muthupandian
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

4.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

Review 5.  COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.

Authors:  Yasmine Benhadid-Brahmi; Samia Hamane; Benjamin Soyer; Alexandre Mebazaa; Alexandre Alanio; Benjamin Chousterman; Stéphane Bretagne; Sarah Dellière
Journal:  J Mycol Med       Date:  2021-11-26       Impact factor: 2.391

Review 6.  Advances in prophylaxis and treatment of invasive fungal infections: perspectives on hematologic diseases.

Authors:  Hyojin Ahn; Raeseok Lee; Sung-Yeon Cho; Dong-Gun Lee
Journal:  Blood Res       Date:  2022-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.